Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD

Rachael L Morton, Iryna Schlackow, Natalie Staplin, Alastair Gray, Alan Cass, Richard Haynes, Jonathan Emberson, William Herrington, Martin J Landray, Colin Baigent, Borislava Mihaylova, SHARP Collaborative Group, Rachael L Morton, Iryna Schlackow, Natalie Staplin, Alastair Gray, Alan Cass, Richard Haynes, Jonathan Emberson, William Herrington, Martin J Landray, Colin Baigent, Borislava Mihaylova, SHARP Collaborative Group

Abstract

Background: The inverse association between educational attainment and mortality is well established, but its relevance to vascular events and renal progression in a population with chronic kidney disease (CKD) is less clear. This study aims to determine the association between highest educational attainment and risk of vascular events, cause-specific mortality, and CKD progression.

Study design: Prospective epidemiologic analysis among participants in the Study of Heart and Renal Protection (SHARP), a randomized controlled trial.

Setting & participants: 9,270 adults with moderate to severe CKD (6,245 not receiving dialysis at baseline) and no history of myocardial infarction or coronary revascularization recruited in Europe, North America, Asia, Australia, and New Zealand.

Predictor: Highest educational attainment measured at study entry using 6 levels that ranged from "no formal education" to "tertiary education."

Outcomes: Any vascular event (any fatal or nonfatal cardiac, cerebrovascular, or peripheral vascular event), cause-specific mortality, and CKD progression during 4.9 years' median follow-up.

Results: There was a significant trend (P<0.001) toward increased vascular risk with decreasing levels of education. Participants with no formal education were at a 46% higher risk of vascular events (relative risk [RR], 1.46; 95% CI, 1.14-1.86) compared with participants with tertiary education. The trend for mortality across education levels was also significant (P<0.001): all-cause mortality was twice as high among those with no formal education compared with tertiary-educated individuals (RR, 2.05; 95% CI, 1.62-2.58), and significant increases were seen for both vascular (RR, 1.84; 95% CI, 1.21-2.81) and nonvascular (RR, 2.15; 95% CI, 1.60-2.89) deaths. Lifestyle factors and prior disease explain most of the excess mortality risk. Among 6,245 participants not receiving dialysis at baseline, education level was not significantly associated with progression to end-stage renal disease or doubling of creatinine level (P for trend = 0.4).

Limitations: No data for employment or health insurance coverage.

Conclusions: Lower educational attainment is associated with increased risk of adverse health outcomes in individuals with CKD.

Trial registration: ClinicalTrials.gov NCT00125593.

Keywords: Chronic kidney failure; Study of Heart and Renal Protection (SHARP); chronic kidney disease (CKD); disease progression; education; educational attainment; end-stage renal disease (ESRD); health behavior; inequalities; mortality; renal dialysis; risk factor; socioeconomic factors; vascular event.

Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Figures

Figure 1
Figure 1
Relevance of highest education level attained to 2,317 vascular events (atherosclerotic and nonatherosclerotic). (A) Total effect: Cox proportional hazards model stratified by country and adjusted for age, sex, black ethnicity, and study treatment assignment. Test for trend χ2 = 16.12; P < 0.001. (B) Residual effect: Cox proportional hazards model stratified by country and adjusted for age, sex, black ethnicity, smoking, alcohol use, body mass index, chronic kidney disease stage, prior vascular disease, diabetes, renal diagnosis, systolic and diastolic blood pressure, albumin level, urinary albumin-creatinine ratio, hemoglobin level, phosphate level, high-density lipoprotein cholesterol level, and total cholesterol level. The size of the square representing a relative risk is proportional to its inverse variance; error bars represent 95% confidence intervals (CIs). Tests for trend in the models were evaluated after excluding participants with unrecorded education. Test for trend χ2 = 0.81; P = 0.4.
Figure 2
Figure 2
Relevance of highest education level attained to vascular, nonvascular, and overall mortality. (A) Total effects: Cox proportional hazards models stratified by country and adjusted for age, sex, black ethnicity, and study treatment assignment. Tests for trend: χ2 = 14.23; P < 0.001 for vascular deaths; χ2 = 29.42; P < 0.001 for nonvascular deaths; χ2 = 51.52; P < 0.001 for all deaths. (B) Residual effects: Cox proportional hazards models stratified by country and adjusted for age, sex, black ethnicity, study treatment assignment, smoking, alcohol use, body mass index, chronic kidney disease stage, prior vascular disease, diabetes, renal diagnosis, systolic and diastolic blood pressure, albumin level, urinary albumin-creatinine ratio, hemoglobin level, phosphate level, high-density lipoprotein cholesterol level, and total cholesterol level. The size of a square representing a relative risk is proportional to its inverse variance; error bars represent 95% confidence intervals (CIs). Tests for trend in all models were evaluated after excluding participants with unrecorded education. Tests for trend: χ2 = 2.76; P = 0.1 for vascular deaths; χ2 = 9.18; P = 0.003 for nonvascular deaths; χ2 = 15.09; P < 0.001 for all deaths.
Figure 3
Figure 3
Relevance of highest education level attained among 6,245 participants not on dialysis therapy at randomization to progression to end-stage renal disease or doubling of creatinine level. Participants with end point, n = 2,446. Test for trend, Wald χ2 = 0.71; P = 0.4. Cox proportional hazards model stratified by country and adjusted for age, sex, black ethnicity, and study treatment assignment. The size of the square representing a relative risk is proportional to its inverse variance; error bars represent 95% confidence intervals (CIs). Tests for trend in all models were evaluated after excluding participants with unrecorded education.

References

    1. Cutler D, Lleras-Muney A. Education and Health: Evaluating Theories and Evidence. Cambridge, MA: National Bureau of Economic Research, Working Paper Series 2006; NBER Working Paper no. 12352 (JEL no. I1, I2):1-37.
    1. Payne R.A., Maxwell S.R. Deprivation-based risk scores: the re-emergence of postcode prescribing in the UK? J Cardiovasc Med. 2009;10(2):157–160.
    1. Philbin E.F., McCullough P.A., DiSalvo T.G., Dec G.W., Jenkins P.L., Weaver W.D. Socioeconomic status is an important determinant of the use of invasive procedures after acute myocardial infarction in New York State. Circulation. 2000;102(suppl 3):107–115.
    1. Stocks N.P., Ryan P., McElroy H., Allan J. Statin prescribing in Australia: socioeconomic and sex differences. A cross-sectional study. Med J Aust. 2004;180(5):229–231.
    1. Stringhini S., Sabia S., Shipley M. Association of socioeconomic position with health behaviors and mortality. JAMA. 2010;303(12):1159–1166.
    1. Cutler D.M., Glaeser E.L., Rosen A.B. Is the US population behaving healthier? In: Brown J.R., Leibman J., Wise D., editors. Social Security Policy in a Changing Environment. National Bureau of Economic Research; Cambridge, MA: 2009. pp. 423–442.
    1. Morton R.L., Schlackow I., Mihaylova B., Staplin N., Gray A., Cass A. The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review [published online ahead of print January 5, 2015] Nephrol Dial Transplant. 2015
    1. Cavanaugh K.L., Wingard R.L., Hakim R.M. Low health literacy associates with increased mortality in ESRD. J Am Soc Nephrol. 2010;21(11):1979–1985.
    1. Xu R., Han Q.F., Zhu T.Y. Impact of individual and environmental socioeconomic status on peritoneal dialysis outcomes: a retrospective multicenter cohort study. PLoS One. 2012;7(11):e50766.
    1. Baigent C., Landray M.J., Reith C. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377(9784):2181–2192.
    1. SHARP Collaborative Group Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. Am Heart J. 2010;160(5):785–794.
    1. von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P., STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573–577.
    1. Levey A.S., Stevens L.A., Schmid C.H. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
    1. Haynes R., Lewis D., Emberson J. Effects of lowering LDL cholesterol on progression of kidney disease. J Am Soc Nephrol. 2014;25(8):1825–1833.
    1. Kleinbaum D.G., Klein M. 3rd ed. Springer; New York, NY: 2012. Survival Analysis.
    1. Schisterman E.F., Cole S.R., Platt R.W. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009;20(4):488–495.
    1. Hosmer D.W., Lemeshow S. 2nd ed. John Wiley & Sons; Hoboken, NJ: 2004. Applied Logistic Regression.
    1. Hosmer D.W., Lemeshow S., Sturdivant R.X. 3rd ed. John Wiley & Sons; Hoboken, NJ: 2013. Applied Logistic Regression.
    1. Plummer M. Improved estimates of floating absolute risk. Stat Med. 2004;23(1):93–104.
    1. Jha P., Ramasundarahettige C., Landsman V. 21st-Century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368(4):341–350.
    1. Ng Fat L., Cable N., Marmot M., Shelton N. Persistent long-standing illness and non-drinking over time, implications for the use of lifetime abstainers as a control group. J Epidemiol Community Health. 2014;68(1):71–77.
    1. Mann D.M., Woodward M., Muntner P., Falzon L., Kronish I. Predictors of nonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother. 2010;44(9):1410–1421.
    1. Alves T.P., Wang X., Wright J.T., Jr. Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis. J Am Soc Nephrol. 2010;21(8):1361–1369.
    1. Babayev R., Whaley-Connell A., Kshirsagar A. Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP) Am J Kidney Dis. 2013;61(3):404–412.
    1. Grundy E., Holt G. The socioeconomic status of older adults: how should we measure it in studies of health inequalities? J Epidemiol Community Health. 2001;55(12):895–904.
    1. Hossain M.P., Palmer D., Goyder E., El Nahas A.M. Association of deprivation with worse outcomes in chronic kidney disease: findings from a hospital-based cohort in the United Kingdom. Nephron. 2012;120(2):c59–c70.
    1. Cole S.R., Platt R.W., Schisterman E.F. Illustrating bias due to conditioning on a collider. Int J Epidemiol. 2010;39(2):417–420.
    1. Gnavi R., Petrelli A., Demaria M., Spadea T., Carta Q., Costa G. Mortality and educational level among diabetic and non-diabetic population in the Turin Longitudinal Study: a 9-year follow-up. Int J Epidemiol. 2004;33(4):864–871.
    1. Steenland K., Henley J., Thun M. All-cause and cause-specific death rates by educational status for two million people in two American Cancer Society cohorts, 1959–1996. Am J Epidemiol. 2002;156(1):11–21.
    1. Choi A.I., Weekley C.C., Chen S.-C. Association of educational attainment with chronic disease and mortality: the Kidney Early Evaluation Program (KEEP) Am J Kidney Dis. 2011;58(2):228–234.
    1. Picciotto S., Forastiere F., Stafoggia M. Associations of area based deprivation status and individual educational attainment with incidence, treatment, and prognosis of first coronary event in Rome, Italy. J Epidemiol Community Health. 2006;60:37–43.
    1. Sheridan S.L., Halpern D.J., Viera A.J., Berkman N.D., Donahue K.E., Crotty K. Interventions for individuals with low health literacy: a systematic review. J Health Commun. 2011;16(suppl 3):30–54.
    1. Miller C.L., Sedivy V. Using a quitline plus low-cost nicotine replacement therapy to help disadvantaged smokers to quit. Tobacco Control. 2009;18(2):144–149.
    1. Napoles A.M., Santoyo-Olsson J., Stewart A.L. Methods for translating evidence-based behavioral interventions for health-disparity communities. Prev Chronic Dis. 2013;10:E193.
    1. Von Wagner C., Steptoe A., Wolf M.S., Wardle J. Health literacy and health actions: a review and a framework from health psychology. Health Educ Behav. 2009;36:860–877.

Source: PubMed

3
Subscribe